NurExone Biologic Inc. (TSXV:NRX)
Canada flag Canada · Delayed Price · Currency is CAD
0.9800
-0.0200 (-2.00%)
Sep 30, 2025, 2:45 PM EDT

NurExone Biologic Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
81441417-
Market Cap Growth
106.33%208.80%-14.84%--
Enterprise Value
79411312-
Last Close Price
0.980.620.290.39-
PB Ratio
38.6517.3557.035.89-
P/TBV Ratio
38.6517.3557.035.89-
Debt / Equity Ratio
0.060.026.440.010.89
Quick Ratio
1.302.080.344.171.67
Current Ratio
1.944.111.044.461.74
Return on Equity (ROE)
-307.77%-517.23%-318.51%-499.17%-
Return on Assets (ROA)
-127.74%-135.79%-92.09%-123.02%-
Return on Capital (ROIC)
-186.21%-195.66%-129.79%-159.74%-
Earnings Yield
-10.67%-16.51%-33.76%-66.15%-
FCF Yield
-8.42%-18.13%-28.40%-31.58%-
Buyback Yield / Dilution
-34.51%-46.27%-18.52%-129.35%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.